Lehloenya, Rannakoe Joseph, Prof


Dr. Rannakoe Lehloenya, commonly referred to as ‘Ranks” is a registered Dermatologist. He graduated from National University of Lesotho with a BSc in 1989 and from MBChB from Medunsa in 1997. After completing internship and community service at Pretoria Academic Hospital and WK Knobel hospitals respectively as we all as a spell as a general practitioner, he came to UCT for his Dermatology training.

He is currently a Consultant Dermatologist at Groote Schuur Hospital, Senior Lecturer in the Division of Dermatology at UCT and the Managing Director of the Dermatology Treatment and Phototherapy Centre in Century City.

Ranks has a special interest in phototherapy, drug reactions, HIV, tuberculosis and other infectious diseases.

Practice Number: PR 0321843

Rates: Medical aid rates apply for hospital admissions.

Education: BSc (NUL), MB ChB (Medunsa) FCDerm (SA)

Professional Membership

Health Professions Council of South Africa

Dermatological Society of South Africa (Executive Committee member)

RegiSCAR (an international organization that drives research on drug reactions)

Faculty 1000


  1. RJ Lehloenya, M Kgokolo. Clinical Presentations of Severe Cutaneous Drug Reactions in HIV-Infected Africans. Dermatologic clinics 32 (2), 227-235
  1. C Kenyon, K Bonorchis, C Corcoran, G Meintjes, M Locketz, RJ Lehloenya et al. A dimorphic fungus causing disseminated infection in South Africa. New England Journal of Medicine 369 (15), 1416-1424
  1. RJ Lehloenya, K Dheda. Cutaneous adverse drug reactions to anti-tuberculosis drugs: state of the art and into the future. Expert review of anti-infective therapy 2012 Apr;10 (4), 475-486
  1. L Knight, R Muloiwa, S Dlamini, RJ Lehloenya. Factors Associated with Increased Mortality in a Predominantly HIV-Infected Population with Stevens Johnson Syndrome and Toxic Epidermal Necrolysis. PloS One. 9 (4), e93543
  1. K Shean, E Streicher, E Pieterson, G Symons, R van Zyl Smit, G Theron, RJ Lehloenya, et al PloS One. 8 (5), e63057. Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa.
  1. GS Tomlinson, TJ Cashmore, PTG Elkington, J Yates, RJ Lehloenya, et al. European journal of immunology 41 (11), 3253-3260. Transcriptional profiling of innate and adaptive human immune responses to mycobacteria in the tuberculin skin test